Scripx Offers Another Opportunity in the Virtual Pharmacy Space - KingsCrowd

Analyst Report: Upgrade for access Scripx Offers Another Opportunity in the Virtual Pharmacy Space

Scripx is a Texas-based prescription fulfillment and delivery startup. While not the first in its space, it offers another opportunity to invest in the space.

 
Details
Company: Scripx Pharmacy & Health on Republic 2022
Security Type: SAFE
Valuation: $12,000,000
Min Investment: $100
Platform: Republic
Deadline: Jan 31, 2023
$1,070,000
Francis Vu - November 29th

Introduction

Compared to only a decade ago, technology has made life far more convenient. Nowadays, I can easily check-in for flights on my phone, have a telehealth visit with my doctor, and have food delivered right to my door. Even highly regulated industries — like prescription medicine — have become easier to access because of technology. The emergence of companies and services like NowRx, Capsule, and others have allowed people to avoid the hassle of going to a pharmacy and waiting in line for their medicine. Instead, they can have prescriptions filled automatically and delivered right to their homes. 

Scripx is following in the footsteps of NowRx and Capsule. It’s a Dallas-based virtual pharmacy operating within the Dallas-Fort Worth metropolitan area. Scripx offers prescription fulfillment and delivery as well as limited telehealth services. Customers can use the company’s mobile app to upload insurance documents, track their prescriptions, and order refills. But there are a few things investors should consider before investing in a duplicative company like Scripx. Rather than blazing a new trail, it’s following the drug delivery service playbook created by NowRX and Capsule. And that comes with its own mix of advantages and disadvantages.

Pay Annually
and save 17%

This article requires: Edge Pro

Full site access including KingsCrowd's qualitative analyst reports.

$
49.95 /month
41.58 /annually
 

What's included

  • Everything in Edge, plus
  • Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
  • Search and filter based on Analyst Reports
  • In-depth risk ratings for every raise

Get access to the first and only premium analytics and rating platform that enables informed startup investments.

Join the KingsCrowd insiders!

Sign up for our 3 minute newsletter with fresh takes on the investments you should know.

We care about the protection of your data. Read our Privacy Policy.